Puretech Health Plc - Adr logo

Puretech Health Plc - Adr Share Price Today

(NASDAQ: PRTC)

Puretech Health Plc - Adr share price is $18.74 & ₹1,629.80 as on 6 Mar 2025, 2.30 'hrs' IST

$18.74

▲

0.44

(2.4%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Puretech Health Plc - Adr share price in Dollar and Rupees. Guide to invest in Puretech Health Plc - Adr stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Puretech Health Plc - Adr, along with analyst recommendations, forecasts, and comprehensive financials.

Puretech Health Plc - Adr share price movements

  • Today's Low: $18.74
    Today's High: $18.74

    Day's Volatility :0.0%

  • 52 Weeks Low: $17.00
    52 Weeks High: $34.00

    52 Weeks Volatility :50.0%

Puretech Health Plc - Adr (PRTC) Returns

PeriodPuretech Health Plc - AdrSector (Health Care)Index (Russel 2000)
3 Months
-12.98%
2.1%
0.0%
6 Months
-16.25%
-4.1%
0.0%
1 Year
-28.43%
2.2%
0.0%
3 Years
-27.84%
11.8%
-11.6%

Puretech Health Plc - Adr (PRTC) Key Statistics

in dollars & INR

Previous Close
$18.3
Open
$18.74
Today's High
$18.74
Today's Low
$18.74
Market Capitalization
$447.1M
Today's Volume
$232.0
52 Week High
$34.0
52 Week Low
$17.0
Revenue TTM
$468.0K
EBITDA
$-134.7M
Earnings Per Share (EPS)
$-3.0
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.62%
Return On Equity TTM
-22.07%

How to invest in Puretech Health Plc - Adr Stock (PRTC) from India?

It is very easy for Indian residents to invest directly in Puretech Health Plc - Adr from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Puretech Health Plc - Adr stock in both Indian Rupees (INR) and US Dollars (USD). Search for Puretech Health Plc - Adr or PRTC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Puretech Health Plc - Adr or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Puretech Health Plc - Adr shares which would translate to 0.046 fractional shares of Puretech Health Plc - Adr as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Puretech Health Plc - Adr, in just a few clicks!

Returns in Puretech Health Plc - Adr (PRTC) for Indian investors in Rupees

The Puretech Health Plc - Adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Puretech Health Plc - Adr investment value today

Current value as on today

₹78,252

Returns

₹21,748

(-21.75%)

Returns from Puretech Health Plc - Adr Stock

₹26,711 (-26.71%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Puretech Health Plc - Adr (PRTC)

-20%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Puretech Health Plc - Adr Stock from India on INDmoney has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Puretech Health Plc - Adr

  • Birch Hill Investment Advisors LLC

    1.26%

  • Millennium Management LLC

    0.19%

  • Pentwater Capital Management LP

    0.10%

  • UBS Group AG

    0.01%

Analyst Recommendation on Puretech Health Plc - Adr

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 6 Wall street analysts offering stock ratings for Puretech Health Plc - Adr(by analysts ranked 0 to 5 stars)

Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
5
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Puretech Health Plc - Adr Stock (PRTC)

What analysts predicted

Upside of 184.15%

Target:

$53.25

Current:

$18.74

Insights on Puretech Health Plc - Adr Stock (Ticker Symbol: PRTC)

  • Price Movement

    In the last 6 months, PRTC stock has moved down by -16.2%

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 90.0K → 288.0K (in $), with an average increase of 43.8% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -20.34M → -41.77M (in $), with an average decrease of 50.9% per quarter

  • PRTC vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 88.2%

  • PRTC vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 82.3%

  • Price to Sales

    ForPRTC every $1 of sales, investors are willing to pay $915.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

PRTC Puretech Health Plc - Adr Financials in INR & Dollars

FY18Y/Y Change
Revenue
$16.4M
↑ 2418.62%
Net Income
$-43.7M
↓ 241.42%
Net Profit Margin
-266.65%
↓ 5015.73%
FY19Y/Y Change
Revenue
$8.7M
↓ 46.93%
Net Income
$421.1M
↓ 1064.73%
Net Profit Margin
4.8K%
↑ 5114.07%
FY20Y/Y Change
Revenue
$8.3M
↓ 3.99%
Net Income
$4.6M
↓ 98.92%
Net Profit Margin
54.77%
↓ 4792.65%
FY21Y/Y Change
Revenue
$10.0M
↑ 19.64%
Net Income
$-62.7M
↓ 1472.79%
Net Profit Margin
-628.41%
↓ 683.18%
FY22Y/Y Change
Revenue
$2.1M
↓ 79.06%
Net Income
$-37.1M
↓ 40.9%
Net Profit Margin
-1.8K%
↓ 1144.99%
FY23Y/Y Change
Revenue
$3.3M
↑ 59.33%
Net Income
$-65.7M
↑ 77.25%
Net Profit Margin
-2.0K%
↓ 199.48%
Q1 FY23Q/Q Change
Revenue
$9.0M
-
Net Income
$-23.1M
-
Net Profit Margin
-256.3%
-
Q2 FY23Q/Q Change
Revenue
$3.2M
↓ 65.03%
Net Income
$-25.0M
↑ 8.3%
Net Profit Margin
-793.81%
↓ 537.51%
Q3 FY23Q/Q Change
Revenue
$90.0K
↓ 97.14%
Net Income
$-20.3M
↓ 18.63%
Net Profit Margin
-22.6K%
↓ 21813.41%
Q1 FY24Q/Q Change
Revenue
$178.6K
↑ 98.41%
Net Income
$-40.4M
↑ 98.41%
Net Profit Margin
-22.6K%
↑ 0.47%
Q2 FY24Q/Q Change
Revenue
$288.0K
↑ 61.28%
Net Income
$-41.8M
↑ 3.48%
Net Profit Margin
-14.5K%
↑ 8102.24%
FY18Y/Y Change
Profit
$-61.0M
↓ 9489.38%
FY19Y/Y Change
Profit
$8.7M
↓ 114.24%
FY20Y/Y Change
Profit
$8.3M
↓ 3.99%
FY21Y/Y Change
Profit
$-100.5M
↓ 1304.8%
FY22Y/Y Change
Profit
$-150.3M
↑ 49.61%
FY23Y/Y Change
Profit
$-1.6M
↓ 98.93%
Q1 FY23Q/Q Change
Profit
$-24.9M
-
Q2 FY23Q/Q Change
Profit
$89.0K
↓ 100.36%
Q3 FY23Q/Q Change
Profit
$-21.5M
↓ 24206.18%
Q1 FY24Q/Q Change
Profit
$-1.7M
↓ 92.18%
Q2 FY24Q/Q Change
Profit
$-38.6M
↑ 2201.98%
FY18Y/Y Change
Operating Cash Flow
$-72.8M
↓ 17.92%
Investing Cash Flow
$-39.6M
↓ 147.38%
Financing Cash Flow
$156.9M
↑ 967.55%
FY19Y/Y Change
Operating Cash Flow
$-98.2M
↑ 34.84%
Investing Cash Flow
$63.7M
↓ 260.57%
Financing Cash Flow
$49.9M
↓ 68.19%
FY20Y/Y Change
Operating Cash Flow
$-131.8M
↑ 34.3%
Investing Cash Flow
$364.5M
↑ 472.55%
Financing Cash Flow
$38.9M
↓ 22.12%
FY21Y/Y Change
Operating Cash Flow
$-158.3M
↑ 20.06%
Investing Cash Flow
$197.4M
↓ 45.85%
Financing Cash Flow
$22.7M
↓ 41.53%
Q4 FY22Q/Q Change
Operating Cash Flow
$-32.6M
↓ 28.85%
Investing Cash Flow
$86.9M
↑ 0.0%
Financing Cash Flow
$45.9M
↓ 480.34%
Q1 FY23Q/Q Change
Operating Cash Flow
$-100.3M
↑ 207.97%
Investing Cash Flow
$86.9M
↑ 0.0%
Financing Cash Flow
$-25.6M
↓ 155.76%
Q2 FY23Q/Q Change
Operating Cash Flow
$-65.1M
↓ 35.06%
Investing Cash Flow
$86.9M
↑ 0.0%
Financing Cash Flow
$91.9M
↓ 458.66%

Puretech Health Plc - Adr Technicals Summary

Sell

Neutral

Buy

Puretech Health Plc - Adr is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Puretech Health Plc - Adr (PRTC) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Puretech Health Plc - Adr logo
Puretech Health Plc - Adr
-5.43%
-16.25%
-28.43%
-27.84%
-62.61%
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
Beone Medicines Ltd
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Puretech Health Plc - Adr logo
Puretech Health Plc - Adr
NA
NA
NA
-4.31
-0.22
-0.13
NA
1.32
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
Beone Medicines Ltd
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Puretech Health Plc - Adr logo
Puretech Health Plc - Adr
Buy
$447.1M
-62.61%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
Beone Medicines Ltd
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
Buy
$31.5B
120.93%
NA
-12.37%

About Puretech Health Plc - Adr

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. It also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; SPT-320, a novel prodrug of agomelatine for the treatment of generalized anxiety disorder; and SPT-348, a prodrug of a non-hallucinogenic neuroplastogen for the treatment of mood and other neuropsychiatric disorders. In addition, the company is developing hydrogels to enable the oral administration of peptide therapeutics in preclinical development. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Organization
Puretech Health Plc - Adr
Employees
90
CEO
Dr. Bharatt M. Chowrira J.D., Ph.D.
Industry
Health Technology

Management People of Puretech Health Plc - Adr

NameTitle
Dr. Bharatt M. Chowrira J.D., Ph.D.
CEO & Executive Director
Ms. Daphne Zohar
Founder, Senior Advisor & Board Observer
Dr. Robert S. Langer Jr., Ph.D., ScD
Co-Founder & Non-Executive Director
Dr. Eric Elenko Ph.D.
Co-Founder & President
Dr. David R. Elmaleh Ph.D.
Co-Founder & Senior Advisor
Ms. Lauren A. White M.B.A.
Chief Financial Officer
Mr. Eric Green M.B.A.
Chief Operating Officer
Ms. Allison Mead Talbot
Head of Communications & Investor Relations
Mr. Charles Sherwood III, J.D., Ph.D.
General Counsel & Company Secretary
Mr. Spencer Ball
Senior Vice President of Human Resources

Important FAQs about investing in PRTC Stock from India :

What is Puretech Health Plc - Adr share price today?

Puretech Health Plc - Adr share price today stands at $18.74, Open: $18.74 ; Previous Close: $18.30 ; High: $18.74 ; Low: $18.74 ; 52 Week High: $34.00 ; 52 Week Low: $17.00.

The stock opens at $18.74, after a previous close of $18.30. The stock reached a daily high of $18.74 and a low of $18.74, with a 52-week high of $34.00 and a 52-week low of $17.00.

Can Indians buy Puretech Health Plc - Adr shares?

Yes, Indians can invest in the Puretech Health Plc - Adr (PRTC) from India.

With INDmoney, you can buy Puretech Health Plc - Adr at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Puretech Health Plc - Adr at zero transaction cost.

How can I buy Puretech Health Plc - Adr shares from India?

It is very easy to buy Puretech Health Plc - Adr from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Puretech Health Plc - Adr (PRTC) be purchased?

Yes, you can buy fractional shares of Puretech Health Plc - Adr with INDmoney app.

What are the documents required to start investing in Puretech Health Plc - Adr stocks?

To start investing in Puretech Health Plc - Adr, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Puretech Health Plc - Adr Stock (PRTC)?

Today’s highest price of Puretech Health Plc - Adr (PRTC) is $18.74.

Today’s lowest price of Puretech Health Plc - Adr (PRTC) is $18.74.

What is today's market capitalisation of Puretech Health Plc - Adr?

Today's market capitalisation of Puretech Health Plc - Adr PRTC is 447.1M

What is the 52 Week High and Low Range of Puretech Health Plc - Adr Stock (PRTC)?

  • 52 Week High

    $34.00

  • 52 Week Low

    $17.00

What are the historical returns of Puretech Health Plc - Adr (PRTC)?

  • 1 Month Returns

    -5.43%

  • 3 Months Returns

    -16.25%

  • 1 Year Returns

    -28.43%

  • 5 Years Returns

    -62.61%

Who is the Chief Executive Officer (CEO) of Puretech Health Plc - Adr ?

Dr. Bharatt M. Chowrira J.D., Ph.D. is the current Chief Executive Officer (CEO) of Puretech Health Plc - Adr.